|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.86 CHF | -0.74% |
|
+1.01% | +14.84% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-10 | Novartis AG : JP Morgan keeps its Buy rating | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVARTIS AG | Other Pharmaceuticals | -0.74% | +1.01% | +14.84% | +31.08% | +47.55% | 295B |  | | |
- Stock Market
- Stocks
- NOVN Stock
- Charts Novartis AG
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
